Efficacy Data | NUPLAZID® (pimavanserin)

^®

Jump to:

Expand all Collapse all

Chart shows SAPS-PD change from baseline through 6-week total study treatment, NUPLAZID vs placebo

Chart shows SAPS-PD change from baseline through 6-week total study treatment, NUPLAZID vs placebo

Chart shows motor function change from baseline to Week 6 in UPDRS Parts II+III (LSM±SE), NUPLAZID® vs placebo

Chart shows motor function change from baseline to Week 6 in UPDRS Parts II+III (LSM±SE), NUPLAZID® vs placebo

Chart shows proportion of patients with SAPS-PD score improvement at the end of Week 6, NUPLAZID vs placebo

Chart shows proportion of patients with SAPS-PD score improvement at the end of Week 6, NUPLAZID vs placebo

Chart shows SAPS-PD change from core baseline to Week 10 by visit, NUPLAZID vs placebo

Chart shows SAPS-PD change from core baseline to Week 10 by visit, NUPLAZID vs placebo

Chart shows proportion of patients with SAPS-PD score improvement at the end of Week 6, NUPLAZID vs placebo

Chart shows proportion of patients with SAPS-PD score improvement at the end of Week 6, NUPLAZID vs placebo

Cookie Settings